MedTrace Logo

Evaluation of the Spectra Optia PMN Cell Collection Procedure

NCT01805180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2015-03-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the procedures for the collection PMN cells on Terumo BCT's Spectra Optia® and COBE® Spectra Apheresis Systems.

Conditions

  • Granulocyte/ Polymorphonuclear Cells

Interventions

DEVICE

Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System)

In Arm 1 the first PMN cell collection will be performed using the Spectra Optia System and the second PMN cell collection using the COBE Spectra System.

DEVICE

Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System)

In Arm 2 the first PMN cell collection will be performed using the COBE Spectra System and the second PMN cell collection using the Spectra Optia System.

Sponsors & Collaborators

  • Terumo BCT

    lead INDUSTRY

Principal Investigators

  • Raymond Goodrich, Ph.D · Terumo BCT

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805180 on ClinicalTrials.gov